PharmaBoardroom

Silvia Casellas – CEO, Anagram, Spain

Silvia Casellas, CEO of Anagram, a Spanish CRO, discusses the challenges of the consolidation process the company has gone in recent years, the…

Lingshi Tan – Founder, Chairman and CEO, dMed, China

Dr Lingshi Tan, chairman and CEO of dMed, shares his strategic insights into the new era of Chinese biotech innovation and how it motivated him to…

Alfonso García Cañamaque – CEO, León Research, Spain

Alfonso García Cañamaque, CEO of León Research, gives an overview of the Spanish clinical research ecosystem and the challenges facing CROs. Also,…

NEW Spain Pharma Report Out Now!

Having largely recovered from the impact of the global financial crisis and with several impressive fundamentals in place, Spain once again stands as…

Ji-Young Lee – Senior Director Clinical Operations, PAREXEL…

Ji-Young Lee, senior director clinical operations, and general management & business administration Korea of PAREXEL Korea discusses the strengths…

Javier Urzay – Deputy Director, Farmaindustria, Spain

Javier Urzay, deputy director of Farmaindustria, gives an overview of the growth of the pharmaceutical sector in Spain and the challenges to find a…

Jin-San Yoo – President & CEO, PharmAbcine, South…

Dr Jin San-Yoo, president and CEO of PharmAbcine, lifts the lid on the company’s combination therapy with MSD’s blockbuster oncology treatment…

Top 10 Clinical CROs in Korea

Ten of the top contract research organizations (CROs) currently operating in South Korea, as selected by KoNECT, the Korea National Enterprise for…

George Lee – Vice-President of Clinical Operations and…

George Lee, vice-president of clinical operations and country leader of PAREXEL in China, discusses the impact of the recent ownership and management…